DocDollars

Romark Laboratories, LC

FL · United States · Reporting entity ID 100000011162

Total reported 2019–2025
$27.8M
#256 of 2,960 reporting companies — 0% of all reported industry payments
$357K in general payments across 7,411 records, plus $22.2M in research funding across 166 records.

How it breaks down

General payments $357,085
Research funding $22,181,573
Ownership & investment $5,280,884

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Romark Laboratories, LC reported $27.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #256 of 2,960 reporting companies. 80% of that was research funding and 20% general payments such as consulting, speaking, food and travel. 7,411 general payment records and 166 research records were filed.

Common questions about Romark Laboratories, LC

How much has Romark Laboratories, LC paid US doctors?

Romark Laboratories, LC reported $27,819,542 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $357,085 in general payments, $22,181,573 in research funding and $5,280,884 in ownership and investment interests.

How does Romark Laboratories, LC rank among drug and device companies?

It ranks #256 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Romark Laboratories, LC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.